4//SEC Filing
Lipocine Inc. 4
Accession 0001638599-16-001676
$LPCNCIK 0001535955operating
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 10:50 AM ET
Size
5.5 KB
Accession
0001638599-16-001676
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Mattila Jyrki
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-12-07$3.61/sh+40,000$144,400→ 40,000 totalExercise: $3.61From: 2017-12-07Exp: 2026-12-07→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 7, 2017, while the remaining 2/3 of the shares subject to the award vesting monthly on a prorata basis over the following two years.
Documents
Issuer
Lipocine Inc.
CIK 0001535955
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001535955
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 10:50 AM ET
- Size
- 5.5 KB